| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.16e-05 | 8 | 120 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.46e-05 | 10 | 120 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.01e-05 | 30 | 120 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 3.44e-05 | 31 | 120 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.09e-05 | 303 | 120 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | chromatin binding | NANOGP8 BCAS3 POLD1 NANOG MSL1 FANCM AHDC1 SBNO2 PPARGC1A SBNO1 KMT2A ELK4 MBD5 HCFC1 | 1.42e-04 | 739 | 120 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.13e-04 | 4 | 120 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.24e-04 | 20 | 120 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone binding | 1.11e-03 | 265 | 120 | 7 | GO:0042393 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 3.70e-06 | 6 | 119 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 1.03e-05 | 8 | 119 | 3 | GO:0140970 | |
| GeneOntologyCellularComponent | chromatin | SHLD2 SETD1A POU6F2 NANOGP8 SPIB BCAS3 BICRA NANOG MSL1 FANCM INO80D HOXA2 PPARGC1A KANSL2 ZSCAN1 BAZ2A ZBED6 MAFB LHX5 ELK4 HCFC1 | 8.70e-05 | 1480 | 119 | 21 | GO:0000785 |
| Domain | AT_hook | 2.37e-05 | 27 | 118 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.37e-05 | 27 | 118 | 4 | IPR017956 | |
| Domain | SNO | 3.96e-05 | 2 | 118 | 2 | IPR026741 | |
| Domain | SBNO_Helicase_C_dom | 3.96e-05 | 2 | 118 | 2 | IPR026937 | |
| Domain | Potential_DNA-bd | 3.96e-05 | 2 | 118 | 2 | IPR025927 | |
| Domain | zf-C3Hc3H | 3.96e-05 | 2 | 118 | 2 | PF13891 | |
| Domain | Helicase_C_4 | 3.96e-05 | 2 | 118 | 2 | PF13871 | |
| Domain | Post-SET_dom | 1.30e-04 | 16 | 118 | 3 | IPR003616 | |
| Domain | PostSET | 1.30e-04 | 16 | 118 | 3 | SM00508 | |
| Domain | AT_hook | 1.30e-04 | 16 | 118 | 3 | PF02178 | |
| Domain | POST_SET | 1.30e-04 | 16 | 118 | 3 | PS50868 | |
| Domain | FYrich_C | 3.91e-04 | 5 | 118 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.91e-04 | 5 | 118 | 2 | IPR003888 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | SM00542 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | SM00541 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | PF05964 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | PF05965 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | PS51543 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | PS51542 | |
| Domain | Helicase/UvrB_N | 1.08e-03 | 8 | 118 | 2 | IPR006935 | |
| Domain | ResIII | 1.08e-03 | 8 | 118 | 2 | PF04851 | |
| Domain | Homeodomain-like | 1.23e-03 | 332 | 118 | 8 | IPR009057 | |
| Domain | GBP_C | 1.72e-03 | 10 | 118 | 2 | PF02841 | |
| Domain | G_GB1_RHD3_dom | 2.10e-03 | 11 | 118 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 2.10e-03 | 11 | 118 | 2 | IPR015894 | |
| Domain | MBD | 2.10e-03 | 11 | 118 | 2 | SM00391 | |
| Domain | MBD | 2.10e-03 | 11 | 118 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 2.10e-03 | 11 | 118 | 2 | IPR001739 | |
| Domain | MBD | 2.10e-03 | 11 | 118 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 2.10e-03 | 11 | 118 | 2 | IPR016177 | |
| Domain | Guanylate-bd_C | 2.10e-03 | 11 | 118 | 2 | IPR003191 | |
| Domain | GBP | 2.10e-03 | 11 | 118 | 2 | PF02263 | |
| Domain | G_GB1_RHD3 | 2.10e-03 | 11 | 118 | 2 | PS51715 | |
| Domain | - | 2.15e-03 | 283 | 118 | 7 | 1.10.10.60 | |
| Domain | SET | 2.20e-03 | 41 | 118 | 3 | PF00856 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.54e-06 | 42 | 74 | 5 | M48018 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.51e-05 | 38 | 74 | 4 | MM17073 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 1.27e-04 | 19 | 74 | 3 | M39544 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 1.27e-04 | 19 | 74 | 3 | MM15973 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.09e-04 | 175 | 74 | 6 | MM14941 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A SPOUT1 PPRC1 BCAS3 BICRA DLL1 AHDC1 SBNO2 PKMYT1 LPIN3 KMT2C MDN1 SSH1 CASKIN1 TLN2 SDF4 SNAPC4 MBD5 HCFC1 PRRT4 RASAL1 | 2.41e-10 | 1105 | 121 | 21 | 35748872 |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 17578910 | ||
| Pubmed | 6.75e-08 | 12 | 121 | 4 | 27563068 | ||
| Pubmed | 2.46e-07 | 16 | 121 | 4 | 23870121 | ||
| Pubmed | 4.06e-07 | 43 | 121 | 5 | 33472061 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AFTPH WASHC2C USP24 ESF1 KANSL2 MDN1 SSH1 BAZ2A ZBTB21 KMT2A UTP20 TLN2 SNAPC4 AKAP1 | 5.48e-07 | 774 | 121 | 14 | 15302935 |
| Pubmed | SETD1A SPOUT1 CWC15 AHDC1 DNAAF8 KMT2C FAM120A SSH1 KMT2A HCFC1 PML | 8.05e-07 | 469 | 121 | 11 | 27634302 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 POU6F2 DCAF6 UBE2K COL26A1 PCDHGB1 BCAS3 BICRA AHDC1 SBNO2 PLEKHG4B KMT2C FAM120A SIGIRR ARID5B MAST1 ELK4 MBD5 BAIAP3 | 9.65e-07 | 1489 | 121 | 19 | 28611215 |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 9.71e-07 | 22 | 121 | 4 | 26886794 | |
| Pubmed | PRUNE2 EXPH5 BRSK2 FANCM CEP68 PARP4 FAM120A SSH1 DISP3 MBD5 FAM135A | 1.31e-06 | 493 | 121 | 11 | 15368895 | |
| Pubmed | 1.80e-06 | 104 | 121 | 6 | 9205841 | ||
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 2.27e-06 | 8 | 121 | 3 | 23130995 | |
| Pubmed | Rebalancing gene haploinsufficiency in vivo by targeting chromatin. | 2.68e-06 | 28 | 121 | 4 | 27256596 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 22665483 | ||
| Pubmed | AFTPH CWC15 POLD1 RAB11FIP1 ESF1 PKMYT1 TBC1D8 MDN1 LLGL1 FAM120A FAM171A2 BAZ2A DDX18 SDF4 AKAP1 ITM2B FAM135A PML | 4.01e-06 | 1487 | 121 | 18 | 33957083 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 24244196 | ||
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 37012455 | ||
| Pubmed | A mouse-specific retrotransposon drives a conserved Cdk2ap1 isoform essential for development. | 8.83e-06 | 12 | 121 | 3 | 34644528 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 20018852 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AFTPH BCAS3 EXPH5 BRSK2 RAB11FIP1 NUAK2 LPIN3 MDN1 FAM171A2 ZBTB21 KMT2A AKAP1 PML | 1.01e-05 | 861 | 121 | 13 | 36931259 |
| Pubmed | DDIT4 UBE2K WASHC2C BRSK2 ADAR PKMYT1 KANSL2 FAM120A BAZ2A MAST1 KMT2A UTP20 PCSK1N FAM135A | 1.13e-05 | 1006 | 121 | 14 | 15226823 | |
| Pubmed | MOF-associated complexes ensure stem cell identity and Xist repression. | 1.15e-05 | 13 | 121 | 3 | 24842875 | |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 24619213 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29618166 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24989131 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 1.20e-05 | 2 | 121 | 2 | 19415763 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33812060 | ||
| Pubmed | The human guanylate-binding proteins hGBP-1 and hGBP-5 cycle between monomers and dimers only. | 1.20e-05 | 2 | 121 | 2 | 28580591 | |
| Pubmed | Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. | 1.20e-05 | 2 | 121 | 2 | 36695974 | |
| Pubmed | PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. | 1.20e-05 | 2 | 121 | 2 | 16511594 | |
| Pubmed | Regulation and enzymatic basis of bone resorption by human osteoclasts. | 1.20e-05 | 2 | 121 | 2 | 17241109 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23357366 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24598770 | ||
| Pubmed | MafB negatively regulates RANKL-mediated osteoclast differentiation. | 1.20e-05 | 2 | 121 | 2 | 17158225 | |
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 1.20e-05 | 2 | 121 | 2 | 22079639 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 1.20e-05 | 2 | 121 | 2 | 21136380 | |
| Pubmed | 1.28e-05 | 146 | 121 | 6 | 21589869 | ||
| Pubmed | 1.70e-05 | 44 | 121 | 4 | 24183668 | ||
| Pubmed | SHLD2 WASHC2C SPOUT1 PPRC1 ESF1 SBNO2 PPARGC1A KMT2C ARID5B SNX27 SDF4 BAIAP3 FAM135A PML | 2.57e-05 | 1084 | 121 | 14 | 11544199 | |
| Pubmed | 2.84e-05 | 50 | 121 | 4 | 37974198 | ||
| Pubmed | 3.11e-05 | 453 | 121 | 9 | 29656893 | ||
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 28401892 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 3.59e-05 | 3 | 121 | 2 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 3.59e-05 | 3 | 121 | 2 | 26660234 | |
| Pubmed | PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. | 3.59e-05 | 3 | 121 | 2 | 28332630 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 3.59e-05 | 3 | 121 | 2 | 18177668 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 3.59e-05 | 3 | 121 | 2 | 17211451 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15502159 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 3.59e-05 | 3 | 121 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 3.59e-05 | 3 | 121 | 2 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 3.59e-05 | 3 | 121 | 2 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 3.59e-05 | 3 | 121 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 3.59e-05 | 3 | 121 | 2 | 23329853 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 3.59e-05 | 3 | 121 | 2 | 26733157 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19763085 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 3.59e-05 | 3 | 121 | 2 | 19582141 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 3.59e-05 | 3 | 121 | 2 | 28636920 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17937892 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20539761 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18260761 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25495651 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18584034 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21969378 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20661723 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 29245050 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23932714 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 11340167 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 3.59e-05 | 3 | 121 | 2 | 15494369 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 11943463 | ||
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 3.59e-05 | 3 | 121 | 2 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 3.59e-05 | 3 | 121 | 2 | 21194951 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22388986 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 3.59e-05 | 3 | 121 | 2 | 18024963 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 3.59e-05 | 3 | 121 | 2 | 25410303 | |
| Pubmed | Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. | 3.59e-05 | 3 | 121 | 2 | 37587260 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 33334884 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 3.59e-05 | 3 | 121 | 2 | 17360937 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 3.59e-05 | 3 | 121 | 2 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 3.59e-05 | 3 | 121 | 2 | 30837263 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 3.59e-05 | 3 | 121 | 2 | 27939294 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18442017 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 3.59e-05 | 3 | 121 | 2 | 22172669 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 3.59e-05 | 3 | 121 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 3.59e-05 | 3 | 121 | 2 | 17554338 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 3.59e-05 | 3 | 121 | 2 | 16259959 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12609610 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 3.59e-05 | 3 | 121 | 2 | 23770853 | |
| Interaction | KANSL3 interactions | 8.10e-07 | 86 | 120 | 7 | int:KANSL3 | |
| Interaction | KAT8 interactions | 1.59e-06 | 95 | 120 | 7 | int:KAT8 | |
| Interaction | HCFC1 interactions | SETD1A NANOG ADAR PPARGC1A KMT2C KANSL2 KMT2A MBD5 HCFC1 PML | 1.03e-05 | 293 | 120 | 10 | int:HCFC1 |
| Interaction | KMT2B interactions | 1.28e-05 | 130 | 120 | 7 | int:KMT2B | |
| Interaction | PHF20 interactions | 1.57e-05 | 53 | 120 | 5 | int:PHF20 | |
| Interaction | TOP3B interactions | SETD1A SPOUT1 PPRC1 BCAS3 BICRA DLL1 AHDC1 SBNO2 PKMYT1 LPIN3 KMT2C MDN1 FAM120A SSH1 CASKIN1 TLN2 SDF4 SNAPC4 MBD5 HCFC1 PRRT4 RASAL1 | 5.10e-05 | 1470 | 120 | 22 | int:TOP3B |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.36e-04 | 34 | 79 | 3 | 487 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.01e-03 | 11 | 79 | 2 | 1025 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL | 1.40e-06 | 172 | 121 | 8 | M45741 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.27e-06 | 200 | 121 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 5.82e-06 | 164 | 121 | 6 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 6.02e-06 | 165 | 121 | 6 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 6.24e-06 | 166 | 121 | 6 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-06 | 171 | 121 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.71e-06 | 176 | 121 | 6 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-06 | 176 | 121 | 6 | 8488997e0f02e874f53fae1690da63e0dd1d0780 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 183 | 121 | 6 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 189 | 121 | 6 | ce3fbaf9642785c8adf6edaeae20998bca558928 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 190 | 121 | 6 | db19c72d8c8053262b535068c5a9d4d696989cb1 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.47e-05 | 193 | 121 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.51e-05 | 194 | 121 | 6 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.44e-05 | 126 | 121 | 5 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 144 | 121 | 5 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.16e-05 | 153 | 121 | 5 | da1bff9928d8c61bb1c389d45fd897cfa4bed023 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.76e-05 | 156 | 121 | 5 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.31e-05 | 163 | 121 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 8.56e-05 | 164 | 121 | 5 | 08c725548e751f815b4df778607270498204b353 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 164 | 121 | 5 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.91e-05 | 86 | 121 | 4 | 79c4326df78f0a5b3ef13b2fb4e5074934536e35 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 166 | 121 | 5 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 166 | 121 | 5 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 167 | 121 | 5 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 167 | 121 | 5 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 167 | 121 | 5 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 167 | 121 | 5 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.59e-05 | 168 | 121 | 5 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 170 | 121 | 5 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 171 | 121 | 5 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 91 | 121 | 4 | 25197fde8b9bdaf1e28add695d13aff3ff52d86e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related-Oligodendrocyte/OPC|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 91 | 121 | 4 | ed4a48e5e5f5d8aadbc7b1b8d84a5f6363a08b85 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 176 | 121 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 177 | 121 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 177 | 121 | 5 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 177 | 121 | 5 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 177 | 121 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 121 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 179 | 121 | 5 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 179 | 121 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 179 | 121 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 182 | 121 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 182 | 121 | 5 | 3a3ed195c15d33d46a2f395cb93018e4bba28353 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 183 | 121 | 5 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.47e-04 | 184 | 121 | 5 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 184 | 121 | 5 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 184 | 121 | 5 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 185 | 121 | 5 | 4e40d3103ebf4a7066b7ce300b6ef700ba0e2863 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 186 | 121 | 5 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 186 | 121 | 5 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.58e-04 | 187 | 121 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 187 | 121 | 5 | 60c2576f31a60f819deb9ec500d1f714b469df4e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 187 | 121 | 5 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.62e-04 | 188 | 121 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.62e-04 | 188 | 121 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 188 | 121 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 188 | 121 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 190 | 121 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.79e-04 | 192 | 121 | 5 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.79e-04 | 192 | 121 | 5 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 192 | 121 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 192 | 121 | 5 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 192 | 121 | 5 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 0208fcd8ea4662f40fc2c072ac220d97823eec12 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 04d47ba7cc1f19f1ffb18d9e68469e75063697cf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-04 | 193 | 121 | 5 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-04 | 193 | 121 | 5 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 1.83e-04 | 193 | 121 | 5 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.83e-04 | 193 | 121 | 5 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-04 | 194 | 121 | 5 | f0467d81063a9b19783906c456935ef8318b9b98 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.88e-04 | 194 | 121 | 5 | 0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed | |
| ToppCell | distal-1-Hematologic-Myeloid_Dendritic_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-04 | 194 | 121 | 5 | 85a4be291c25ad1fb14199b87d822cf47d748fc0 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.88e-04 | 194 | 121 | 5 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.92e-04 | 195 | 121 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.92e-04 | 195 | 121 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 195 | 121 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 1.97e-04 | 196 | 121 | 5 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.97e-04 | 196 | 121 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 196 | 121 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 197 | 121 | 5 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 197 | 121 | 5 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 2.02e-04 | 197 | 121 | 5 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.02e-04 | 197 | 121 | 5 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-04 | 197 | 121 | 5 | 2b58ac5d70e1ebd9bf9f2b60ee8079337a723658 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-04 | 197 | 121 | 5 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 197 | 121 | 5 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 197 | 121 | 5 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 198 | 121 | 5 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-04 | 107 | 121 | 4 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | mLN-(1)_T_cell-(16)_Tfh|mLN / shred on region, Cell_type, and subtype | 2.11e-04 | 199 | 121 | 5 | c66fb7473c4bd990685ff47c3d9168d10ef39c9b | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.11e-04 | 199 | 121 | 5 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | mLN-T_cell-Tfh|mLN / Region, Cell class and subclass | 2.11e-04 | 199 | 121 | 5 | 65b7dea8ec19df9afc5cc06bb632c2e70e30a5da | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.11e-04 | 199 | 121 | 5 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.11e-04 | 199 | 121 | 5 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A | 7.80e-06 | 192 | 119 | 8 | 1525_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; HL60; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 2917_UP | |
| Drug | ytterbium | 1.01e-05 | 55 | 119 | 5 | CID000023992 | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 6240_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 3082_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A | 1.01e-05 | 199 | 119 | 8 | 1738_DN | |
| Drug | AC1L9LBW | 1.14e-05 | 9 | 119 | 3 | CID000447867 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A | 3.82e-05 | 175 | 119 | 7 | 4651_UP | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; PC3; HT_HG-U133A | 6.02e-05 | 188 | 119 | 7 | 4010_UP | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.22e-05 | 189 | 119 | 7 | 4998_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.43e-05 | 190 | 119 | 7 | 4155_UP | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 6.65e-05 | 191 | 119 | 7 | 6319_UP | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 2520_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 7435_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 4313_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 3137_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 5063_DN | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 6361_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 4181_UP | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 2903_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 3865_DN | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 1244_DN | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; HL60; HG-U133A | 8.33e-05 | 198 | 119 | 7 | 1787_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; HL60; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 2518_UP | |
| Disease | response to virus | 8.38e-04 | 11 | 117 | 2 | GO_0009615 | |
| Disease | colon cancer (implicated_via_orthology) | 8.38e-04 | 11 | 117 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | prediabetes syndrome (biomarker_via_orthology) | 1.00e-03 | 12 | 117 | 2 | DOID:11716 (biomarker_via_orthology) | |
| Disease | gout | 1.13e-03 | 196 | 117 | 5 | EFO_0004274 | |
| Disease | Hypercalcemia | 1.18e-03 | 13 | 117 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 1.18e-03 | 13 | 117 | 2 | C0026141 | |
| Disease | feeling emotionally hurt measurement | 1.45e-03 | 56 | 117 | 3 | EFO_0009599 | |
| Disease | focal segmental glomerulosclerosis | 1.80e-03 | 16 | 117 | 2 | EFO_0004236 | |
| Disease | Abnormal behavior | 1.80e-03 | 16 | 117 | 2 | C0233514 | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 1.80e-03 | 16 | 117 | 2 | EFO_0801688 | |
| Disease | ischemia (implicated_via_orthology) | 2.04e-03 | 17 | 117 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.63e-03 | 69 | 117 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | glaucoma | 3.35e-03 | 154 | 117 | 4 | MONDO_0005041 | |
| Disease | atrial fibrillation | 3.69e-03 | 371 | 117 | 6 | EFO_0000275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PADPATLSEDEARLL | 36 | P06881 | |
| PLSDDDQFSPEADAA | 831 | Q92667 | |
| ETPPLEDLAANQSED | 206 | Q9P2K9 | |
| QADSPPADLLLTEEE | 206 | Q9BRK5 | |
| DLAPPALDSVLEASA | 531 | A6NC98 | |
| NEAASELPDTAENLP | 971 | Q96M83 | |
| TEDDPSLADLPQALD | 151 | Q76N32 | |
| PSLPQEQEESLADSL | 491 | O94812 | |
| PNIDPTEENDLDDSL | 396 | Q6ULP2 | |
| SCLDDPSHLPDQLED | 276 | Q9UIF9 | |
| DEDLDLDTPPQTAAL | 1226 | Q5VU97 | |
| AEAEDAEDAALPALP | 111 | Q6IQ19 | |
| DQIPAANLDADDPLT | 96 | Q9P013 | |
| LQDTDDSDDDPVLIP | 651 | Q58WW2 | |
| PDSLESQLLDPQALD | 321 | Q5TGY3 | |
| SDTPQPLLDFDTDDL | 771 | Q9H6U6 | |
| PAEEDTASPLALLEE | 281 | O95294 | |
| PEDEFDDPQALAVLL | 351 | Q15334 | |
| ALAPADSLNDPAIES | 1716 | P51610 | |
| ALASANLADEPVPDA | 956 | Q8WXD9 | |
| LSSDDDAPDSPVILE | 561 | Q9BQK8 | |
| PEALDLPDDLNLDSE | 4876 | Q9NU22 | |
| PADDPLADISEVLNT | 1426 | Q8NEZ4 | |
| NPEALNLTPEDAVEA | 96 | Q9Y5Q3 | |
| EDEAPLALSDAEQPP | 201 | Q8N9B5 | |
| DDVILNEPSADAPAA | 96 | Q9Y287 | |
| PENDENCLPLTEDEL | 401 | Q9HC44 | |
| PLPAAAEAQLESDDD | 41 | Q8IYD8 | |
| PILNAADADVPLDDL | 1211 | Q5SZK8 | |
| ASQLESDTIADLPDP | 576 | Q13585 | |
| SLPSLEDIDPDVLDS | 291 | Q8IWQ3 | |
| ASEEELPSDVDLNDP | 656 | Q9H501 | |
| NSLPSDDELSPDENS | 841 | Q9P2D6 | |
| DDDPDAPAAQLARAL | 126 | Q9UHG2 | |
| ADSLQEVLPDLSDRP | 661 | Q9Y5G3 | |
| ELAEEDFLAVSPLDP | 96 | Q63ZY6 | |
| PNSPASDLEAALEAA | 256 | Q9H9S0 | |
| DEPNLESLQSEPREL | 1526 | Q8NEV8 | |
| LSPDLQDALQDDPKE | 141 | Q9H2C1 | |
| AQNLEAEASPEEELP | 611 | Q8N3J3 | |
| SLDLEADGQPLTPDE | 186 | P32455 | |
| AQLETLPDDELEPEF | 246 | Q96PP8 | |
| SIEDEANKDLPPAAL | 586 | Q9NZB2 | |
| SANSSPSELADELPD | 86 | Q7Z3K6 | |
| QPDLDVDLPDLASES | 861 | Q9UKK3 | |
| NDEDESEVPSLPLGL | 156 | Q9NVP1 | |
| LRDPNPSDLLENLDD | 486 | Q68DK7 | |
| LLEPSRFSAPQEDED | 801 | Q9Y2H9 | |
| LCSPEDNSLTPLLDE | 741 | A8MVW0 | |
| DNSLTPLLDEVAAPE | 746 | A8MVW0 | |
| PDLPELDLSELDVND | 31 | Q9UBK2 | |
| KLDDNLLPSEEDPAL | 486 | Q9Y2L6 | |
| LLPSEEDPALQELES | 491 | Q9Y2L6 | |
| IQDALDASDFEAPPE | 541 | Q0VDD7 | |
| ADPFSDRLDDVEQPL | 506 | Q8NA47 | |
| TDDIPDDLNSIRAAP | 456 | P55265 | |
| ELPENLSLEPKDQDS | 291 | P28324 | |
| VSLPDFELLSDPEDE | 76 | Q9NX09 | |
| SPDDLATENPERLIS | 131 | O00548 | |
| LIPDLSEELAEDPAD | 61 | Q8IYS4 | |
| LDPEDPTLRDSDLLS | 496 | P48740 | |
| EDDLRNPDSPSSNEL | 1361 | Q9P267 | |
| TPELSADELPDDIAN | 591 | Q53TQ3 | |
| ELQPTESLPLEFSDD | 396 | Q9H9L4 | |
| SAEEQFELPLELPSD | 2916 | Q03164 | |
| LDLELDSSDEEGPQL | 651 | Q5T1A1 | |
| DLAPAEASPLSAQDA | 321 | O60269 | |
| NQPAPSVDLDFLEDD | 66 | Q9NZM4 | |
| QDNPALDIDDDLPTF | 591 | P51170 | |
| AEDLPPNTLDELIDE | 866 | A3KN83 | |
| DDAPRPSQFEEDLAL | 26 | P28340 | |
| LEDELQEQPDDLTLP | 326 | Q5VV67 | |
| LLLEAAERPSSPDND | 151 | Q96A83 | |
| NTPLLDEIDPDSAEE | 151 | O15247 | |
| ADADPNLEVAEPSVL | 321 | Q5T280 | |
| LPSSEEDNDDAKILP | 81 | Q6PGQ1 | |
| LDENDNAPALLATPA | 556 | Q9UN75 | |
| PDDLAPALEDSLSQE | 491 | Q7Z6I6 | |
| FSVEPPLDDLSLDEA | 566 | Q7Z6I6 | |
| NDSPEALEVPSLQDF | 311 | O43364 | |
| LDSVFPDPEDLLNSR | 211 | Q693B1 | |
| LSPEGEDQESLLQPD | 1091 | Q5JY77 | |
| VDDLLNLPDFEPTET | 1256 | O75691 | |
| NLSLPSIPEVASDDE | 956 | Q6WKZ4 | |
| ELNSLEVPLSPDDES | 1831 | O60522 | |
| ENPALVPDALLASDT | 2276 | Q8WUY3 | |
| EDAEPLLPLQSALSA | 1746 | O14513 | |
| PSFPEEAALEAEAEL | 1131 | Q58EX7 | |
| PNSPASDLEAALEAA | 256 | Q6NSW7 | |
| ELNEPLLAPVESNDS | 41 | P78424 | |
| LDENLADPQAEDRPL | 596 | P29590 | |
| ADLVAEESPELLNPE | 471 | Q6P5W5 | |
| PEEAEAEELSPLLSN | 21 | Q8IZM9 | |
| DRAPDFLSPSEDQVL | 6 | Q6IA17 | |
| ELFSSEDELPPNEIR | 341 | Q86V20 | |
| DIVDTPDFLPADSLN | 116 | Q9Y2G9 | |
| SESFDQLDLPERLPE | 551 | Q9H093 | |
| EEDLPLDSPALEVSD | 131 | Q01892 | |
| ALFSSPADEVLEAPE | 1326 | O15047 | |
| LEASIPEESQDPAAL | 851 | Q8WYL5 | |
| PADPATLSEDEARLL | 36 | P01258 | |
| AAEAPTDDQPTDLSL | 896 | Q14865 | |
| SPTLLDADFPDSDLN | 516 | Q9ULJ3 | |
| LDPDTANPELILSED | 291 | Q96F44 | |
| TPRDALDLSDINSEP | 461 | Q99640 | |
| ENELDELDPDNALLP | 31 | P28289 | |
| PSPSLEQADSDALDI | 11 | A6NEE1 | |
| LRLEEALSEAAPDPS | 596 | Q96PX9 | |
| LDNEVFDLDPDLQEP | 256 | O95759 | |
| DTAIDAAPSAPLDLE | 561 | Q9NS62 | |
| LDAVAAAPALPEESE | 161 | Q8NBB4 | |
| DSPEPASELQAEEAL | 861 | C9JH25 | |
| PPHEADNLDPSDDSL | 136 | Q96L92 | |
| NPFPLLEDEDDLFTD | 1176 | Q9Y4E1 | |
| AQLPEDELFARSSDP | 201 | O00507 | |
| IEVSNPSLLDPDQDA | 291 | O14788 | |
| SLPNAPTLADLEDDT | 111 | Q68CL5 | |
| LSLQALLAAAEPDDP | 111 | P61086 | |
| LLAAAEPDDPQDAVV | 116 | P61086 | |
| ADAPALLASNDPEQD | 96 | P86452 | |
| PGLPESLLSVDDDTD | 1711 | Q9UPU5 | |
| QAQDDLSELDSLPPL | 511 | Q9Y4G6 | |
| SEADSLPSEDLDPAD | 41 | Q5SXM2 | |
| ALQDVPDPEPSSLDD | 36 | A2RU30 | |
| EAELRDELLDSPPAS | 201 | O15069 | |
| LLPSDLRSEQDPTDE | 306 | P28698 |